Global Intravascular Catheters Market – Industry Trends and Forecast to 2029

Global Intravascular Catheters Market, by Product (Short PIVC Catheters and Integrated/Closed PIVC Catheters), Application (Renal Disease, Cancer, Gastrointestinal Diseases, Infectious Diseases and other Diseases), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare and others)– Industry Trends and Forecast to 2029.

Market Analysis and Size

Intravascular Ultrasound (IVUS) is a diagnostic procedure that allows doctors to see a coronary artery in real-time. IVUS is a catheter-based medical imaging procedure that allows doctors to determine the severity of stenosis, or the narrowing or thickening of an artery. This process produces a visible image of the lumen, the inside of the artery, and the atheroma, which is the membrane or cholesterol-laden white blood cells buried within the arterial wall.

Data Bridge Market Research analyses that the intravascular catheters market which was USD 557.3 million in 2021, would rocket up to USD 1135.14 million by 2029, and is expected to undergo a CAGR of 9.30% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

An intravascular ultrasonography catheter is an imaging catheter used to assess vascular morphology in coronary and peripheral blood arteries. It shows cross-sectional photographs of vessels in this type. It has a cylindrical ultrasound transducer array that emits acoustic energy into the surrounding tissue and measures the ultrasonic echoes that result.

Report Scope and Market Segmentation

Intravascular Catheters Market Dynamics

Drivers

• Growing incidence of Diseases

According to the World Health Organization (WHO), cancer is the second biggest cause of death worldwide. In 2018, cancer claimed the lives of more than 9.6 million people around the world. The growing usage of catheters for minimally invasive diagnostic and treatment procedures and the rising hospitalization rate due to the high incidence of chronic diseases are likely to fuel market growth.

• Low cost and easy insertion technique

The product segment for intravascular catheters is dominated by short PIVC. Healthcare providers use short PIVC due to its inexpensive cost and simple insertion technique in approved sites such as the wrist or antecubital vein. The frequent movement of the inserted needle, which causes phlebitis, infiltration, and dislodgment, bringing agony and anguish to the sick patient, is a constraint linked with short PIVC. Because of its intrinsic features, such as an enhanced stabilization frame that lowers inserted catheter movement and eliminates the need for additional securement devices, integrated PIVC is gaining a lot of traction. The use of an integrated PIVC has reduced the incidence of phlebitis and bloodstream infections caused by catheters (CABSI).

• Growing demand for minimal invasive surgical procedures pertaining to trauma incidence

According to the World Health Organization (WHO), 17.9 million people die each year as a result of cardiovascular problems around the world. Scientists believe that early surgical intervention can help to reduce this high mortality rate, which accounts for 31% of all fatalities worldwide. The other applications market is growing due to rising demand for minimally invasive surgical treatments for cardiovascular disease and trauma patients.

• Rising prevalence of hospital-acquired infection and existence of sophisticated healthcare infrastructure

North America now owns a 32% market share and is the clear leader in the intravascular catheters market in the regional sector. The increased prevalence of hospital-acquired infections and the presence of advanced healthcare infrastructure are two significant factors contributing to its market domination. Due to advantageous reimbursement scenarios for intravascular catheters and a considerable increase in the number of impatient procedures conducted to treat chronic diseases, Europe is currently in second place in the regional segment with a 30% share.

Opportunities

The governments of each country have enacted various laws and regulations in order to give medical coverage to millions of people. Over the forecast period of 2022 to 2029, programs like as the Child Health Insurance Program in the United States (CHIP), which provides low-cost coverage for youngsters and, in some cases, pregnant women, will contribute to the market's growth. The infectious diseases segment would expand the most due to the rising incidence of infectious diseases such as HIV, TB, and HPV. Hospital admissions and healthcare providers will undoubtedly grow as these diseases become more common. Intravascular catheters will be in high demand as a result of this.

Restraints/Challenges

The risk of bloodstream infections associated with intravascular catheter use and a scarcity of competent healthcare workers are two main factors limiting the worldwide intravascular catheters market's growth and, also because of high cost associated with the intravascular catheters.

This intravascular catheters market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intravascular catheters market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Intravascular Catheters Market

Due to the COVID-19 pandemic, the demand for intravascular ultrasound (IVUS) devices has enlarged. According to the American College of Cardiology (ACC), around 40% of the COVID-19 recovered patients develop cardiovascular conditions. North America and Asia Pacific regions are the major contributors to the market growth owed to a few factors such as the increase in the need of IVUS actions during PCI procedures and the increase in the acceptance of IVUS systems in hospitals and diagnostic centers.

Global Intravascular Catheters Market Scope

The intravascular catheters market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Short PIVC
• Integrated/Closed PIVC

Application

• Oncology
• Gastroenterology
• Renal Disease
• Infectious Diseases
• Others

End-User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Setting
• Others

Intravascular Catheters Market Regional Analysis/Insights

The intravascular catheters market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.

The countries covered in the intravascular catheters market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to exhibit maximum growth during the forecast period. The growing healthcare expenditure and growing medical tourism in the evolving economies of Asia-Pacific such as India and China are a major contributors to the growth of the intravascular catheter market in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The intravascular catheters market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intravascular catheters market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intravascular catheters market. The data is available for historic period 2010-2020.

Competitive Landscape and Intravascular Catheters Market Share Analysis

The intravascular catheters market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intravascular catheters market.

Some of the major players operating in the intravascular catheters market are:

• Abbott (U.S)
• BD (U.S)
• Boston Scientific Corporation (U.S)
• Medtronic (Ireland)
• Cook (U.S)
• Johnson & Johnson Private Limited (U.S)
•  Smith & Nephew plc (Germany)
• Cardinal Health (U.S)
• Terumo Corporation (Japan)
• Conavi Medical (U.S)
• Edwards Lifesciences Corporation (U.S)
• Infraredx, Inc. (U.S)
• Getinge AB (Sweden)
• Coloplast Corp (Denmark)
•  McKesson Medical-Surgical (U.S)